Skip to main content
. 2012 Jan;167(1):32–39. doi: 10.1111/j.1365-2249.2011.04500.x

Table 1.

Summary of the involvement of invariant natural killer T (iNKT) cells in transplant tolerance (a) and rejection (b). It should be noted that in one study in islet transplantation iNKT cells were not shown to contribute to either transplant tolerance or rejection [35]

Species Transplant Tolerance regimen Mechanism of action Ref.
(a)
Mice Heart Anti-LFA-1/ICAM-1 or anti-B7-1/B7-2 IFN-γ production? [33]
Anti-CD154 mAb iNKT cells require CXCL16/CXCR6 interactions to traffic to allograft [38]
Anti-CD154 mAb IL-10 production [41]
Mice Skin None IL-10 production [37]
Mice Heart Anti-CD4, CD8, CD154 mAb Not determined *
Mice Islet (rat xenograft) Anti-CD4 mAb IFN-γ production but the dose of CD4 is critical for tolerance induction [42]
Mice Cornea None Enhanced regulatory T cell function [43]
Mice Bone marrow None Prevent GVHD. IL-4-dependent [44,45]
(b)
Mice Islet None IFN-γ production promotes PMN recruitment to graft [46]
None Islet destruction only found when islets injected into portal vein [34]
Rapamycin Not determined [34]
Mice Skin Anti-CD4, CD8, CD154 mAb Not determined *
Mice Skin None Induction of a Th17 response **

GVHD: graft-versus-host disease; mAb: monoclonal antibody; Th: T helper; IFN: interferon; PMN: polymorphonuclear; IL: interleukin; LFA: leucocyte function antigen; ICAM: intercellular adhesion molecule.

*

Jukes J-P, Zhao Z & Jones ND, unpublished observations

**

Janes SE & Jones ND, manuscript in preparation.